Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

NCT01921998 · clinicaltrials.gov ↗

SUSPENDED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Trial has been suspended due to lack of resource and staff

Conditions

Lymphoma
Sarcoma

Interventions

PROCEDURE: Biomarker and health economics

Sponsor

The Christie NHS Foundation Trust